Brazilian and Danish scientists discovered that symptoms of depression in rats were reduced upon treatment with cannabidiol (CBD), with results lasting up to seven days. In this controlled study, researchers observed 367 rats and mice during stressful events to see if cannabidiol, given at various strengths, allowed the animals to perform better. The rats and mice that received CBD performed the tests in an anti-depressed manner, in comparison to, those that were given a placebo. One week after the initial tests were performed, various areas of the brain associated with depression were monitored; researchers found that the tested areas of the brain were functioning better after a single treatment of cannabidiol.
Researchers are continuing the scope of their study to determine if cannabidiol, in conjunction with SSRIs (selective serotonin reuptake inhibitors), will provide patients with quicker and longer-lasting relief. Traditional anti-depressants prescribed to humans often require a month to demonstrate any significant improvement and, at times, are not effective at all. Researchers believe that these patients may also be able to reduce their dosages of SSRIs while maintaining the same benefits. Researchers concluded that “cannabidiol may not only be a faster-acting antidepressant than conventional drugs but also improve the response to such drugs when taken in combination with them.” This particular study represents a breakthrough for those suffering from depression, especially those who do not respond to traditional anti-depressant therapy.
To learn more about this study, please see the link here: https://www.sciencedaily.com/releases/2018/08/180830113004.htm.